Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Inogen, Inc (INGN : NSDQ)
 
 • Company Description   
Inogen Inc. develops, manufactures and markets POC. POCs are used by patients who suffer from chronic respiratory conditions and need long-term oxygen therapy. POCs concentrate the air around the patient, filter out the nitrogen and other unwanted substances and deliver oxygen. The company provides oxygen concentrator solutions for portable and stationary use. Inogen's flagship product, One G4 is a single-solution POC.

Number of Employees: 1,021

 
 • Price / Volume Information   
Yesterday's Closing Price: $25.89 Daily Weekly Monthly
20 Day Moving Average: 188,942 shares
Shares Outstanding: 22.84 (millions)
Market Capitalization: $591.22 (millions)
Beta: 1.01
52 Week High: $82.35
52 Week Low: $22.51
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -8.06% 0.33%
12 Week -9.29% -4.50%
Year To Date -23.85% -11.24%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
301 COROMAR DRIVE
-
GOLETA,CA 93117
USA
ph: 805-562-0500
fax: -
ir@inogen.net http://www.inogen.com
 
 • General Corporate Information   
Officers
Nabil Shabshab - Chief Executive Officer; President
Elizabeth Mora - Chairperson of the Board
Michael Sergesketter - Chief Financial Officer
Benjamin Anderson-Ray - Director
Heather Rider - Director

Peer Information
Inogen, Inc (ABMD)
Inogen, Inc (DMDS)
Inogen, Inc (CPWY.)
Inogen, Inc (EQUR)
Inogen, Inc (ECIA)
Inogen, Inc (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 45780L104
SIC: 3842
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/03/22
Share - Related Items
Shares Outstanding: 22.84
Most Recent Split Date: (:1)
Beta: 1.01
Market Capitalization: $591.22 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.39 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-1.63 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/03/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 1.65
Price/Cash Flow: 38.47
Price / Sales: 1.68
EPS Growth
vs. Year Ago Period: -1,166.67%
vs. Previous Quarter: 62.38%
Sales Growth
vs. Year Ago Period: -7.53%
vs. Previous Quarter: 5.21%
ROE
03/31/22 - -3.83
12/31/21 - -1.70
09/30/21 - 3.11
ROA
03/31/22 - -2.89
12/31/21 - -1.28
09/30/21 - 2.34
Current Ratio
03/31/22 - 5.32
12/31/21 - 5.35
09/30/21 - 5.60
Quick Ratio
03/31/22 - 4.75
12/31/21 - 4.83
09/30/21 - 5.07
Operating Margin
03/31/22 - -4.06
12/31/21 - -1.77
09/30/21 - 3.21
Net Margin
03/31/22 - -5.64
12/31/21 - -1.77
09/30/21 - 3.21
Pre-Tax Margin
03/31/22 - -0.84
12/31/21 - 2.42
09/30/21 - 2.91
Book Value
03/31/22 - 15.69
12/31/21 - 16.29
09/30/21 - 17.20
Inventory Turnover
03/31/22 - 5.76
12/31/21 - 6.19
09/30/21 - 6.66
Debt-to-Equity
03/31/22 - -
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - -
12/31/21 - 0.00
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©